W. Mehnert

Publications80
h-index31
Citations9,556
Highly Influential Citations313
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • R. Müller
  • 422 Publications • 40,892 Citations
  • M. Schäfer-Korting
  • 268 Publications • 9,755 Citations
  • H. Korting
  • 389 Publications • 13,421 Citations
  • K. Westesen
  • 57 Publications • 3,141 Citations
  • Publications
  • Influence
Solid lipid nanoparticles: production, characterization and applications.
View on PubMed
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
View on PubMed
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
View on PubMed
Lipid nanoparticles for improved topical application of drugs for skin diseases.
View on PubMed
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
View via Publisher
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron…
View on PubMed
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
TLDR
The SLNs appear suitable as a drug carrier system for potential intravenous use due to their very low cytotoxicity in vitro, compared to polyalkylcyanoacrylate and polylactic/glycolic acid (PLA/ GA) nanoparticles.
View on Springer
Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.
TLDR
The optimized production parameters previously established for drug-free SLN dispersions can therefore be transferred to drug-loaded systems to facilitate product development.
View on PubMed
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
TLDR
Solid lipid nanoparticles of optimized composition proved to be physically stable during sterilization (autoclaving) and on long-term as aqueous dispersion as well as in vitro drug release over 5 weeks (prednisolone).
Solid lipid nanoparticles (SLN) for controlled drug delivery
View via Publisher
...
...